Author:
Aliev R. A.,Zagryadskiy V. A.,Latushkin S. T.,Moiseeva A. N.,Novikov V. I.,Unezhev V. N.,Kazakov A. G.
Publisher
Springer Science and Business Media LLC
Subject
Nuclear Energy and Engineering
Reference9 articles.
1. C. Müller, C. Vermeulen, U. Köster, et al., “Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics,” EJNMMI Radiopharm. Chem., 1, No. 5, 1–5 (2017).
2. G.-J. Beyer, M. Miederer, S. Vranjes-Durić, et al., “Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab,” Eur. J. Nucl. Med. Mol. Imag., 31, No. 4, 547–554 (2004).
3. C. Müller, J. Reber, S. Haller, et al., “Folate receptor targeted alpha-therapy using terbium-149,” Pharmaceuticals, 7, No. 3, 353–365 (2014).
4. M. Maiti, “New measurement of cross sections of evaporation residues from the natPr + 12C reaction: a comparative study on the production of 149Tb,” Phys. Rev. C, 84, No. 4, 1–7 (2011).
5. S. Qaim, B. Scholten, and B. Neumaier, “New developments in the production of theranostic pairs of radionuclides,” J. Radioanal. Nucl. Chem., 318, No. 3, 1493– 1509 (2018).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献